Gilead Sciences GILD Competitive Landscape Shifts As MSD Gains FDA Approval For Dual HIV Therapy Idvynso Lichen LICN Stock Outlook Growth Potential and Key Risks Smart Money Active 20260420 LYG Lloyds posts 288 percent Q4 2025 EPS beat and 77 percent YoY revenue growth shares dip 106 percent today Welltower Inc WELL Activist Investor Land Buildings Challenges Executive Compensation Plan Amid Mixed Market Sentiment